head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2023, vol. 29, issue4
Subject Area: Medicine
DOI: 10.5272/jimab.2023294.5272
Published online: 12 December 2023

Original article
J of IMAB. 2023 Oct-Dec;29(4):5272-5275
Biser K. Borisov1ORCID logoCorresponding Autoremail, Dimitar B. Borisov2ORCID logo,
1) Department of Nephrology and Dialysis, Medical University, Pleven, Bulgaria.
2) Departement of Vascular Surgery, Medical University, Sofia, Bulgaria.

Purpose. The arterio-venous anastomosis (AVA) continues to be the "gold standard" for vascular access in patients undergoing haemodialysis. This retrospective study aims to analyze the causes that led to End Stage Renal Disease (ESRD), the type of native AVA, their localization, and their patency.
Material and Methods. The study included the last 100 consecutive and random AVAs constructed in our clinic. 68 men of average age 62.3 (+/-10.8) years and 32 women of average age 59.9 (+/-15.8) years were operated. The main causes that led to ESRD were: Glomerulonephritis - 33%, Hypertension- 24% and Diabetes- 20%. The overweight patients were 33% and the smokers - 30%.
Results. AVA has been successfully constructed in 82% of the patients on the left hand and in 18% on the right hand. A distal latero-terminal radio-cephalic fistula (DLTRC) was constructed on only 8% of the patients. The most common type of anastomosis was an L.T. radio-cephalic in the forearm - 58%, followed by an L.T. brachio-cephalic fistula - 19% and latero-lateral, radio-cephalic in the forearm - 14% of the patients. The early fistula patency was - 80%, one-year cumulative patency was 94%.
Conclusion. The analysis of our results shows that the relative share of the overweight and diabetes population is increasing today. In practice, solutions for the construction of primary forearm anastomosis are increasingly common.

Keywords: hemodialysis, vascular access, arterio-venous anastomosis, fistula patency,

pdf - Download FULL TEXT /PDF 672 KB/
Please cite this article as: Borisov BK, Borisov DB. Arterio-Venous Fistula Creation for Hemodialysis. What is happening in Bulgaria? J of IMAB. 2023 Oct-Dec;29(4):5272-5275. [Crossref - 10.5272/jimab.2023294.5272]

Corresponding AutorCorrespondence to: Biser Borisov, MD, PhD, Department of Nephrology and Dialysis, Faculty of Medicine, Medical University, Pleven; 8A, George Kochev str., 5800 Pleven, Bulgaria; E-mail: biserugo@abv.bg

1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015 May 16;385(9981):1975-82. [PubMed]
2. Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy. Am J Nephrol. 2021;52(2):98-107. [PubMed]
3. Lawson JH, Niklason LE, Roy-Chaudhury P. Challenges and novel therapies for vascular access in haemodialysis. Nat Rev Nephrol. 2020 Oct;16(10):586-602. [PubMed]  
4. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 2002 Oct;62(4):1109-24. [PubMed]
5. Ratcliffe PJ, Phillips RE, Oliver DO. Late referral for maintenance dialysis. Br Med J (Clin Res Ed). 1984 Feb 11;288(6415):441-3. [PubMed]
6. Khatri N, Nasir K, Dhrolia M, Qureshi R, Ahmad A. Delay in Permanent Vascular Access Formation and Referral to a Nephrologist in Incident Hemodialysis Patients: A Single Center Experience. Cureus. 2021 Dec 27;13(12):e20728. [PubMed]
7. NKF KDOQI GUIDELINES. Clinical Practice Guidelines and Clinical Practice Recommendations. 2006 Updates. Hemodialysis Adequacy. Peritoneal Dialysis Adequacy. Vascular Access. National Kidney Foundation. [Internet]
8.Craig R, Mindell J. Health Survey for England 2006: Volume 1 Cardiovascular Disease and Risk Factors in Adults. January 2008. [Internet]
9. Hemadneh MK, Khatib ST, Hasan SA, Tahboub IN, Khazneh E, Zyoud SH. Diabetes-related knowledge in diabetic haemodialysis patients: a cross-sectional study from Palestine. Ren Replace Ther. 2019; 5:45. [Crossref ]
10.  United States Renal Data System. 2013 USRDS Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2013. [Internet]
11. Yevzlin AS, Villiant AM. Interventional Nephrology: Novel Devices that Will One Day Change Our Practice. Clin J Am Soc Nephrol.  2013 Jul;8(7):1244-51. [PubMed]
12. Venkatnarayanan R, Dogra PM, Bavdekar R, Singh SK, Mondal AK. Primary Failure of Autogenous Arteriovenous Fistula: Critical Analysis. Indian J Nephrol. 2020 Nov-Dec;30(6):382-390. [PubMed]
13. Al-Jaishi AA, Oliver MJ, Thomas SM, Lok CE, Zhang JC, Garg AX, et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2014 Mar;63(3):464-78. [PubMed]
14. Kim JJ, Gifford E, Nguyen V, Kaji AH, Chisum P, Zeng A, et al. Increased use of brachiocephalic arteriovenous fistulas improves functional primary patency. J Vasc Surg. 2015 Aug;62(2):442-447. [PubMed]
15. Allon M. Vascular Access for Hemodialysis Patients: New Data Should Guide Decision Making. Clin J Am Soc Nephrol. 2019 Jun 7;14(6): 954-961. [PubMed]

Received: 27 May 2023
Published online: 12 December 2023

back to Online Journal